CORC

在结果中检索

CORC

浏览/检索结果: 共24条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
A randomized, controlled, multi-center, open-label study of adjuvant nab-paclitaxel plus S-1 (AS) versus capecitabine plus oxaliplatin (CapeOX) for stage III gastric cancer after D2 resection. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Yu, Pengfei;  Du, Yian;  Xu, Zhiyuan;  Yang, Litao;  Ying, Jieer
收藏  |  浏览/下载：9/0  |  提交时间：2022/12/23
Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy 期刊论文
2019, 卷号: 18
作者:  Chen, Li;  Hao, Ying;  Cong, Xiliang;  Zou, Menghua;  Li, Sen
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase I 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 28
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：43/0  |  提交时间：2020/01/03
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30
作者:  Xiong, Jianping;  Qin, Shukui;  Li, Jin;  Wang, Liwei;  Xu, Jianming
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study 期刊论文
2018, 卷号: 6, 期号: 10, 页码: 373-383
作者:  Ren, Deng-Feng;  Zheng, Fang-Chao;  Zhao, Jun-Hui;  Shen, Guo-Shuang;  Ahmad, Raees
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer 期刊论文
2018, 卷号: 18, 期号: 1, 页码: 547
作者:  Wang, Guoxiu;  Zhao, Jiuda;  Song, Yan;  Zhang, Wen;  Sun, Yongkun
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Hypoxia induces universal but differential drug resistance and impairs anticancer mechanisms of 5-fluorouracil in hepatoma cells 期刊论文
ACTA PHARMACOLOGICA SINICA, 2017, 卷号: 38, 期号: 12, 页码: 1642-1654
作者:  Li, Jing-qiu;  Wu, Xian;  Gan, Lu;  Yang, Xiang-liang;  Miao, Ze-hong
收藏  |  浏览/下载：29/0  |  提交时间：2019/01/08
A phase III trial (ZJBIO009): CMAB009 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients 期刊论文
Journal of Clinical Oncology, 2017, 卷号: 35
作者:  Shi Y., Li J., Xu J., Cheng Y., Liu W., Cheng Y., Bai L., Zhang Y., He X., Luo Y., Liu Y., Yao Q., Li Y., Qin S., Hu X., Guo Y., Sun Y.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Adjuvant chemotherapy for chemotherapy-naive advanced gastric cancer patients with oxaliplatin plus tegafur versus oxaliplatin plus S-1 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 卷号: 10, 期号: 6
作者:  Ding, Dayong;  Li, Yongchao;  Shu, Zhenbo
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Postoperative chemotherapy with S-1 plus oxaliplatin versus S-1 alone in locally advanced gastric cancer (RESCUE-GC study): a protocol for a phase III randomized controlled trial 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29, 期号: 2
作者:  Hu, Xiang;  Chen, Lin;  Du, Yian;  Fan, Biao;  Bu, Zhaode
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace